|
|
 |
|
Total Number of Holdings (excluding cash): 51
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
150 |
$45,924.00 |
2.42% |
| Teleflex Incorporated |
TFX |
879369106 |
326 |
$44,518.56 |
2.35% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
10,500 |
$43,425.26 |
2.29% |
| Align Technology, Inc. |
ALGN |
016255101 |
223 |
$42,283.03 |
2.23% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
495 |
$41,654.25 |
2.19% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
86 |
$41,470.92 |
2.18% |
| Baxter International Inc. |
BAX |
071813109 |
2,250 |
$40,860.00 |
2.15% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
427 |
$40,509.49 |
2.13% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,240 |
$39,906.22 |
2.10% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
138 |
$39,721.92 |
2.09% |
| LivaNova Plc |
LIVN |
G5509L101 |
615 |
$39,483.00 |
2.08% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,268 |
$39,082.58 |
2.06% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
361 |
$38,868.43 |
2.05% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
4,434 |
$38,828.62 |
2.05% |
| Agilent Technologies, Inc. |
A |
00846U101 |
335 |
$38,709.25 |
2.04% |
| Boston Scientific Corporation |
BSX |
101137107 |
624 |
$38,731.68 |
2.04% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
565 |
$38,747.70 |
2.04% |
| Masimo Corporation |
MASI |
574795100 |
216 |
$38,584.08 |
2.03% |
| Penumbra, Inc. |
PEN |
70975L107 |
117 |
$38,597.13 |
2.03% |
| Steris Plc |
STE |
G8473T100 |
173 |
$38,371.40 |
2.02% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
337 |
$38,232.65 |
2.01% |
| Becton, Dickinson and Company |
BDX |
075887109 |
250 |
$38,035.00 |
2.00% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,940 |
$37,777.43 |
1.99% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
414 |
$37,781.64 |
1.99% |
| Waters Corporation |
WAT |
941848103 |
121 |
$37,494.27 |
1.98% |
| Alcon Inc. |
ALC.SW |
H01301128 |
494 |
$37,317.44 |
1.97% |
| Revvity, Inc. |
RVTY |
714046109 |
430 |
$37,311.10 |
1.97% |
| Stryker Corporation |
SYK |
863667101 |
114 |
$37,336.14 |
1.97% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
574 |
$37,188.49 |
1.96% |
| DexCom, Inc. |
DXCM |
252131107 |
603 |
$37,126.71 |
1.96% |
| Insulet Corporation |
PODD |
45784P101 |
196 |
$37,153.76 |
1.96% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
29 |
$37,191.05 |
1.96% |
| ResMed Inc. |
RMD |
761152107 |
169 |
$37,154.65 |
1.96% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
167 |
$37,271.85 |
1.96% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,355 |
$36,984.27 |
1.95% |
| Medtronic Plc |
MDT |
G5960L103 |
442 |
$36,827.44 |
1.94% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,860 |
$36,885.87 |
1.94% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
193 |
$36,709.99 |
1.93% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
78 |
$36,637.38 |
1.93% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,711 |
$36,210.70 |
1.91% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
527 |
$36,273.41 |
1.91% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
871 |
$36,165.76 |
1.91% |
| Danaher Corporation |
DHR |
235851102 |
203 |
$35,981.75 |
1.90% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,299 |
$36,029.31 |
1.90% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,285 |
$36,079.79 |
1.90% |
| Abbott Laboratories |
ABT |
002824100 |
385 |
$35,085.05 |
1.85% |
| The Cooper Companies, Inc. |
COO |
216648501 |
542 |
$34,915.64 |
1.84% |
| Hoya Corporation |
7741.JP |
J22848105 |
194 |
$34,792.58 |
1.83% |
| BioMerieux |
BIM.FP |
F1149Y232 |
365 |
$30,349.66 |
1.60% |
| Cochlear Limited |
COH.AU |
Q25953102 |
317 |
$22,069.47 |
1.16% |
| US Dollar |
$USD |
|
7,539 |
$7,538.75 |
0.40% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|